Skip to main content
SpringerLink
Log in

Health Canada consulting on drug pricing regulations

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Canadian dollars

References

  1. Health Canada. Protecting Canadians from Excessive Drug Prices: Consulting on Proposed Amendments to the Patented Medicines Regulations. Internet Document : 16 May 2017. Available from: URL: https://www.canada.ca/en/health-canada/programs/consultation-regulations-patented-medicine/document.html.

  2. Health Canada. Government of Canada taking action to protect Canadians from high prescription drug prices Internet Document : 16 May 2017. Available from: URL: https://www.canada.ca/en/health-canada/news/2017/05/government_of_canadatakingactiontoprotectcanadiansfromhighprescr.html#wb-info.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Health Canada consulting on drug pricing regulations. PharmacoEcon Outcomes News 779, 35 (2017). https://doi.org/10.1007/s40274-017-4050-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4050-4

Search

Navigation